Skip to content

Clinical trials

Active, not recruiting Phase 2 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Status: Active, not recruiting Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20213
20222
20232
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Alumis Inc1
Beeline Medicines Corporation1
Beijing Mabworks Biotech Co., Ltd.1
Cartesian Therapeutics1
GlaxoSmithKline1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1
Northwell Health1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic14
Autoimmune Diseases2
Connective Tissue Diseases2
Immune System Diseases2
Lupus Nephritis2
Arthritis, Rheumatoid1
Lupus Erythematosus, Cutaneous1
Lupus Erythematosus, Discoid1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.